5-Hydroxytryptamine (serotonin) subtype 3 antagonists, a major step in prophylaxis and control of cytostatic and radiation-induced emesis.
作者信息
Bremer K
机构信息
Augusta-Kranken-Anstalt Bochum, Federal Republic of Germany.
出版信息
J Cancer Res Clin Oncol. 1991;117(1):85-7. doi: 10.1007/BF01613203.
Abstract
摘要
相似文献
1
5-Hydroxytryptamine (serotonin) subtype 3 antagonists, a major step in prophylaxis and control of cytostatic and radiation-induced emesis.5-羟色胺（血清素）3型拮抗剂，是预防和控制细胞毒性药物及放射诱导呕吐的重要一步。
J Cancer Res Clin Oncol. 1991;117(1):85-7. doi: 10.1007/BF01613203.
2
Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.用于预防和治疗儿童化疗引起的恶心和呕吐的止吐药物。
Cochrane Database Syst Rev. 2016 Feb 2;2(2):CD007786. doi: 10.1002/14651858.CD007786.pub3.
3
Blueprint for the control of radiation-induced nausea and vomiting. Discussion.辐射诱发恶心和呕吐的控制蓝图。讨论。
Acta Oncol. 2004 Sep;43 Suppl 15:23-4. doi: 10.1080/11001700410016170.
4
Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.用于预防和治疗儿童化疗引起的恶心和呕吐的止吐药物。
Cochrane Database Syst Rev. 2010 Sep 8(9):CD007786. doi: 10.1002/14651858.CD007786.pub2.
5
Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review.神经激肽-1 受体拮抗剂治疗化疗所致恶心呕吐的系统评价。
J Natl Cancer Inst. 2012 Sep 5;104(17):1280-92. doi: 10.1093/jnci/djs335. Epub 2012 Aug 21.
6
Prophylaxis of radiation-induced nausea and vomiting using 5-hydroxytryptamine-3 serotonin receptor antagonists: a systematic review of randomized trials.5-羟色胺 3（5-HT3）受体拮抗剂预防放射性恶心和呕吐的随机试验系统评价。
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):408-17. doi: 10.1016/j.ijrobp.2010.08.060. Epub 2010 Nov 13.
7
Clinical update on palonosetron in the management of chemotherapy-induced nausea and vomiting.帕洛诺司琼治疗化疗引起的恶心和呕吐的临床进展
Tumori. 2008 Jul-Aug;94(4):447-52. doi: 10.1177/030089160809400401.
8
Antiemetics: American Society of Clinical Oncology clinical practice guideline update.止吐药：美国临床肿瘤学会临床实践指南更新。
J Clin Oncol. 2011 Nov 1;29(31):4189-98. doi: 10.1200/JCO.2010.34.4614. Epub 2011 Sep 26.
9
Efficacy of the combination neurokinin-1 receptor antagonist, palonosetron, and dexamethasone compared to others for the prophylaxis of chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials.与其他药物相比，神经激肽-1受体拮抗剂帕洛诺司琼与地塞米松联合用于预防化疗引起的恶心和呕吐的疗效：一项随机对照试验的系统评价和荟萃分析
Ann Palliat Med. 2018 Apr;7(2):221-233. doi: 10.21037/apm.2018.03.09.
10
Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?5-羟色胺3型受体拮抗剂在难治性患者中疗效存在差异是否有药理学依据？
Cancer Chemother Pharmacol. 2005 Sep;56(3):231-8. doi: 10.1007/s00280-005-1033-0. Epub 2005 Apr 19.
引用本文的文献
1
A systematic review of methodologies, endpoints, and outcome measures in randomized trials of radiation therapy-induced nausea and vomiting.放射治疗引起的恶心和呕吐随机试验中方法、终点和结局指标的系统评价。
Support Care Cancer. 2017 Jun;25(6):2019-2033. doi: 10.1007/s00520-017-3685-9. Epub 2017 Mar 31.
2
Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension.血清素在急慢性肺动脉高压发病机制中的作用
Thorax. 1999 Feb;54(2):161-8. doi: 10.1136/thx.54.2.161.
本文引用的文献
1
Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.大剂量甲氧氯普胺的止吐疗效：在化疗引起的恶心和呕吐患者中与安慰剂和丙氯拉嗪的随机试验
N Engl J Med. 1981 Oct 15;305(16):905-9. doi: 10.1056/NEJM198110153051601.
2
On the receiving end--patient perception of the side-effects of cancer chemotherapy.在接受端——患者对癌症化疗副作用的认知
Eur J Cancer Clin Oncol. 1983 Feb;19(2):203-8. doi: 10.1016/0277-5379(83)90418-2.
3
Effects of metoclopramide on isolated guinea-pig colon. 2. Interference with ganglionic stimulant drugs.胃复安对豚鼠离体结肠的作用。2. 对神经节兴奋药的干扰。
Eur J Pharmacol. 1970;12(3):332-41. doi: 10.1016/0014-2999(70)90085-3.
4
Pharmacological analysis of the effects of metoclopramide on the guinea-pig ileum in vitro.甲氧氯普胺对豚鼠离体回肠作用的药理学分析。
Arch Int Pharmacodyn Ther. 1973 Aug;204(2):293-305.
5
Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.大剂量顺铂给药后迟发性恶心和呕吐的发生率、病程及严重程度。
J Clin Oncol. 1985 Oct;3(10):1379-84. doi: 10.1200/JCO.1985.3.10.1379.
6
Extrapyramidal reactions with metoclopramide.胃复安引起的锥体外系反应。
Br Med J (Clin Res Ed). 1985 Oct 5;291(6500):930-2. doi: 10.1136/bmj.291.6500.930.
7
Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.优化癌症化疗中的止吐治疗：高剂量甲氧氯普胺持续输注与间歇输注对顺铂所致呕吐的疗效比较
Br Med J (Clin Res Ed). 1986 Nov 22;293(6558):1334-7. doi: 10.1136/bmj.293.6558.1334.
8
Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism.选择性5-羟色胺M受体拮抗作用对顺铂所致呕吐的抑制作用
Br J Pharmacol. 1986 Jul;88(3):497-9. doi: 10.1111/j.1476-5381.1986.tb10228.x.
9
Ondansetron with and without dexamethasone to treat chemotherapy-induced emesis.昂丹司琼联合或不联合地塞米松治疗化疗引起的呕吐。
Lancet. 1989 Jun 10;1(8650):1323. doi: 10.1016/s0140-6736(89)92711-6.
10
Proceedings of the Ondansetron Symposium. London, 30 June 1989.昂丹司琼研讨会会议记录。伦敦，1989年6月30日。
Eur J Cancer Clin Oncol. 1989;25 Suppl 1:S1-93.
Zotero 插件